Diagnostics

Single Assay Adequate for Screening Certain HBV Patients

Published in Blood Weekly, August 10th, 1998

A single asparate-aminotransferase assay reading can determine the risk of chronic active hepatitis in patients with positive hepatitis B surface antigen and antibodies to hepatitis B e antigen.

Researcher F. Borg and colleagues found that the addition of hepatitis B virus DNA assays did not improve upon the diagnostic findings of aspartate-aminotransferase.

Hepatitis B surface antigen (HBsAg) and antibodies to hepatitis B e antigen (anti-HBe) coexist, and laboratory tests are often requested to assess histological hepatitis activity. To date, an optimum panel of tests has not been found and the usefulness of HBV DNA assays in this context has not...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1998-08-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry